Prohance and contrast media reaction Patient Reports February 13, 2012

Prohance Side Effects Report #5527976-3
Prohance side effect was reported by a Consumer or non-health professional from JAPAN on Nov 15, 2007. Female patient, 64 years of age, weighting 115.5 lb, was diagnosed with nuclear magnetic resonance imaging brain and was treated with Prohance. After drug was administered, patient experienced the following side effects: acute myocardial infarction, blood pressure increased, contrast media reaction, depressed level of consciousness, heart rate decreased, loss of consciousness, somnolence, yawning. Prohance dosage: unknown. During the same period patient was treated with NORVASC, DIOVAN, RABEPRAZOLE, YODEL, GASTER, BALANCE, IRINATOLON, PREDONINE. Patient recovered.

Prohance Side Effects Report #4559728-5
Prohance side effect was reported by a Health Professional from on Feb 12, 2004. Female patient, 50 years of age, weighting 220.5 lb, was diagnosed with asthenia, back pain , nuclear magnetic resonance imaging and was treated with Prohance. After drug was administered, patient experienced the following side effects: contrast media reaction. Prohance dosage: 17 ML ONCE IV. During the same period patient was treated with VALIUM. Patient was hospitalized. Patient recovered.

Prohance Side Effects Report #4559747-9
Prohance side effect was reported by a Health Professional from on June 15, 2004. Female patient, 78 years of age, was diagnosed with arthralgia, nuclear magnetic resonance imaging and was treated with Prohance. After drug was administered, patient experienced the following side effects: contrast media reaction. Prohance dosage: 15 ML ONCE IV. Patient was hospitalized. Patient recovered.

Prohance Side Effects Report #5366986-6
Prohance side effect was reported by a Consumer or non-health professional from UNITED STATES on June 15, 2007. Male patient, 71 years of age, was diagnosed with renal scan and was treated with Prohance. After drug was administered, patient experienced the following side effects: contrast media reaction, nephrogenic fibrosing dermopathy. Prohance dosage: ADMINISTERED 0.32 MILLIMOLES/KILOGRAM. During the same period patient was treated with OMNISCAN, NONE REPORTED. Patient recovered.